日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Recent advances in addressing the market failure of new antimicrobials: Learnings from NICE's subscription-style payment model

解决新型抗菌药物市场失灵问题的最新进展:从NICE的订阅式支付模式中汲取经验

Schurer, Marieke; Patel, Renu; van Keep, Marjolijn; Horgan, Jake; Matthijsse, Suzette; Madin-Warburton, Matthew

Lessons learned from rapid exome sequencing for 575 critically ill patients across the broad spectrum of rare disease

从对涵盖广泛罕见病谱的575名危重患者进行快速外显子组测序中汲取的经验教训

Marouane, Abderrahim; Neveling, Kornelia; Deden, A Chantal; van den Heuvel, Simone; Zafeiropoulou, Dimitra; Castelein, Steven; van de Veerdonk, Frank; Koolen, David A; Simons, Annet; Rodenburg, Richard; Westra, Dineke; Mensenkamp, Arjen R; de Leeuw, Nicole; Ligtenberg, Marjolijn; Matthijsse, Rene; Pfundt, Rolph; Kamsteeg, Erik Jan; Brunner, Han G; Gilissen, Christian; Feenstra, Ilse; de Boode, Willem P; Yntema, Helger G; van Zelst-Stams, Wendy A G; Nelen, Marcel; Vissers, Lisenka E L M

Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis

利用模拟模型估算宫颈癌发生的自然史:CISNET比较分析

Burger, Emily A; de Kok, Inge M C M; Groene, Emily; Killen, James; Canfell, Karen; Kulasingam, Shalini; Kuntz, Karen M; Matthijsse, Suzette; Regan, Catherine; Simms, Kate T; Smith, Megan A; Sy, Stephen; Alarid-Escudero, Fernando; Vaidyanathan, Vivek; van Ballegooijen, Marjolein; Kim, Jane J

Management and treatment of cervical intraepithelial neoplasia in the Netherlands after referral for colposcopy

在荷兰,宫颈上皮内瘤变患者转诊进行阴道镜检查后的管理和治疗。

Aitken, Clare A; Siebers, Albert G; Matthijsse, Suzette M; Jansen, Erik E L; Bekkers, Ruud L M; Becker, Jeroen H; Ter Harmsel, Bram; Roovers, Jan-Paul W R; van Kemenade, Folkert J; de Kok, Inge M C M

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study

在常规筛查中使用 SurePath、ThinPrep 和传统细胞学方法获得正常细胞学样本后宫颈癌的发病率:一项基于人群的研究

Rozemeijer, Kirsten; Naber, Steffie K; Penning, Corine; Overbeek, Lucy I H; Looman, Caspar W N; de Kok, Inge M C M; Matthijsse, Suzette M; Rebolj, Matejka; van Kemenade, Folkert J; van Ballegooijen, Marjolein

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models

人乳头瘤病毒疫苗接种后的人群水平影响、群体免疫和消除:基于传播动力学模型预测的系统评价和荟萃分析

Brisson, Marc; Bénard, Élodie; Drolet, Mélanie; Bogaards, Johannes A; Baussano, Iacopo; Vänskä, Simopekka; Jit, Mark; Boily, Marie-Claude; Smith, Megan A; Berkhof, Johannes; Canfell, Karen; Chesson, Harrell W; Burger, Emily A; Choi, Yoon H; De Blasio, Birgitte Freiesleben; De Vlas, Sake J; Guzzetta, Giorgio; Hontelez, Jan A C; Horn, Johannes; Jepsen, Martin R; Kim, Jane J; Lazzarato, Fulvio; Matthijsse, Suzette M; Mikolajczyk, Rafael; Pavelyev, Andrew; Pillsbury, Matthew; Shafer, Leigh Anne; Tully, Stephen P; Turner, Hugo C; Usher, Cara; Walsh, Cathal

Concerted Efforts to Control or Eliminate Neglected Tropical Diseases: How Much Health Will Be Gained?

共同努力控制或消除被忽视的热带病:能获得多少健康益处?

de Vlas, Sake J; Stolk, Wilma A; le Rutte, Epke A; Hontelez, Jan A C; Bakker, Roel; Blok, David J; Cai, Rui; Houweling, Tanja A J; Kulik, Margarete C; Lenk, Edeltraud J; Luyendijk, Marianne; Matthijsse, Suzette M; Redekop, William K; Wagenaar, Inge; Jacobson, Julie; Nagelkerke, Nico J D; Richardus, Jan H

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis

在部分接种过HPV疫苗的人群中开展宫颈癌筛查——一项成本效益分析

Naber, Steffie K; Matthijsse, Suzette M; Rozemeijer, Kirsten; Penning, Corine; de Kok, Inge M C M; van Ballegooijen, Marjolein

The potential harms of primary human papillomavirus screening in over-screened women: a microsimulation study

对过度筛查女性进行初次人乳头瘤病毒筛查的潜在危害:一项微观模拟研究

Naber, Steffie K; de Kok, Inge M C M; Matthijsse, Suzette M; van Ballegooijen, Marjolein

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates

以SurePath、ThinPrep和传统细胞学作为主要检测方法进行比较:SurePath与更高的CIN II+检出率相关。

Rozemeijer, Kirsten; Penning, Corine; Siebers, Albert G; Naber, Steffie K; Matthijsse, Suzette M; van Ballegooijen, Marjolein; van Kemenade, Folkert J; de Kok, Inge M C M